The U.S. accounts for slightly more than a third of India’s pharmaceutical exports, primarily consisting of cheaper generic versions of popular drugs. Sales in the country rose 20 percent to approximately $10.5 billion in fiscal 2025.
The U.S. accounts for slightly more than a third of India’s pharmaceutical exports, primarily consisting of cheaper generic versions of popular drugs. Sales in the country rose 20 percent to approximately $10.5 billion in fiscal 2025.
:
Published on 07, Sep 2025